ThermoGenesis Holdings, Inc. (THMO)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jul 23, 2025, 8:00 PM EDT
ThermoGenesis Holdings Market Cap
ThermoGenesis Holdings has a market cap or net worth of $16.00 as of July 25, 2025. Its market cap has decreased by -100.00% in one year.
Market Cap
16.00
Enterprise Value
4.33M
Revenue
9.61M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since May 1, 1992, ThermoGenesis Holdings's market cap has decreased from 16.75M to 16.00, a decrease of -100.00%. That is a compound annual growth rate of -34.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2025 | 16.00 | -99.86% |
| Dec 31, 2024 | 11.09K | -99.41% |
| Dec 29, 2023 | 1.89M | -42.37% |
| Dec 30, 2022 | 3.27M | -72.81% |
| Dec 31, 2021 | 12.03M | -26.16% |
| Dec 31, 2020 | 16.29M | 30.23% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.81B |
| Veradigm | 789.71M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 590.95M |
| Glass House Brands | 435.78M |
| Northwest Biotherapeutics | 377.68M |
| CytoDyn | 371.09M |